Allergy and asthma

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 5, 2005, Pages 953-959

  Bochner, Bruce S ^a   Busse, William W ^b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Airway smooth muscle; Asthma; Cysteinyl leukotrienes; Eosinophils; Mast cells

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 5 ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEMBRANE RECEPTOR; MEPOLIZUMAB; MONTELUKAST; NITRIC OXIDE; OMALIZUMAB; PEPTIDOLEUKOTRIENE; PRANLUKAST; PROSTANOID; PROTEIN KINASE SYK INHIBITOR; SCH 55700; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGY; ASTHMA; BASOPHIL; BREATHING MUSCLE; CELL ACTIVATION; CELL TYPE; CLINICAL FEATURE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DENDRITIC CELL; DOSE RESPONSE; DRUG EFFECT; EOSINOPHIL; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HOST SUSCEPTIBILITY; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; MAST CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 18144425180     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.02.032     Document Type: Review

References (37)

1. M. Radinger, A.K. Johansson, B. Sitkauskiene, M. Sjostrand, and J. Lotvall Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure J Allergy Clin Immunol 113 2004 1109 1116
2. C. Duez, A. Dakhama, A. Tomkinson, P. Marquillies, A. Balhorn, and A.B. Tonnel Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge J Allergy Clin Immunol 114 2004 820 825
3. J.J. Lee, D. Dimina, M.P. Macias, S.I. Ochkur, M.P. McGarry, and K.R. O'Neill Defining a link with asthma in mice congenitally deficient in eosinophils Science 305 2004 1773 1776
4. A.A. Humbles, C.M. Lloyd, S.J. McMillan, D.S. Friend, G. Xanthou, and E.E. McKenna A critical role for eosinophils in allergic airways remodeling Science 305 2004 1776 1779
5. P. Flood-Page, A. Menzies-Gow, S. Phipps, S. Ying, A. Wangoo, and M.S. Ludwig Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics J Clin Invest 112 2003 1029 1036
6. J.K. Garrett, S.C. Jameson, B. Thomson, M.H. Collins, L.E. Wagoner, and D.K. Freese Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes J Allergy Clin Immunol 113 2004 115 119
7. S.G. Plotz, H.U. Simon, U. Darsow, D. Simon, E. Vassina, and S. Yousefi Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis N Engl J Med 349 2003 2334 2339
8. Y.J. Kim, C. Prussin, B. Martin, M.A. Law, T.P. Haverty, and T.B. Nutman Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700 J Allergy Clin Immunol 114 2004 1449 1455
9. J.B. Sedgwick, R.F. Vrtis, K.J. Jansen, H. Kita, K. Bartemes, and W.W. Busse Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin J Allergy Clin Immunol 114 2004 568 574
10. D.W. MacGlashan Jr., B.S. Bochner, D.C. Adelman, P.M. Jardieu, A. Togias, and J. McKenzie-White Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody J Immunol 158 1997 1438 1445
11. C. Prussin, D.T. Griffith, K.M. Boesel, H. Lin, B. Foster, and T.B. Casale Omalizumab treatment downregulates dendritic cell FcεRI expression J Allergy Clin Immunol 112 2003 1147 1154
12. L.A. Beck, G.V. Marcotte, D. MacGlashan, A. Togias, and S. Saini Omalizumab-induced reductions in mast cell FcεRI expression and function J Allergy Clin Immunol 114 2004 527 530
13. H. Lin, K.M. Boesel, D.T. Griffith, C. Prussin, B. Foster, and F.A. Romero Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils J Allergy Clin Immunol 113 2004 297 302
14. C.L. Kepley, L. Youssef, R.P. Andrews, B.S. Wilson, and J.M. Oliver Syk deficiency in nonreleaser basophils J Allergy Clin Immunol 104 1999 279 284
15. B. Guyer, S. Shimamoto, A. Bradhurst, E. Grossbard, S. Dreskin, and H. Nelson The effect of a novel inhibitor of mast cell activation on mediators, symptoms and nasal patency in allergic rhinitis J Allergy Clin Immunol 113 suppl 2004 S28 S29
16. D. MacGlashan, and K. Miura Loss of syk kinase during IgE-mediated stimulation of human basophils J Allergy Clin Immunol 114 2004 1317 1324
17. K. Zhang, C.L. Kepley, T. Terada, D. Zhu, H. Perez, and A. Saxon Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcε bifunctional fusion protein J Allergy Clin Immunol 114 2004 321 327
18. A.D. Klion, P. Noel, C. Akin, M.A. Law, D.G. Gilliland, and J. Cools Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness Blood 101 2003 4660 4666
19. S. Jogie-Brahim, H.K. Min, Y. Fukuoka, H.Z. Xia, and L.B. Schwartz Expression of alpha-tryptase and beta-tryptase by human basophils J Allergy Clin Immunol 113 2004 1086 1092
20. A. Mochizuki, A.R. McEuen, M.G. Buckley, and A.F. Walls The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation J Allergy Clin Immunol 112 2003 102 108
21. S. Saini, D.C. Bloom, A. Bieneman, K. Vasagar, A. Togias, and J. Schroeder Systemic effects of allergen exposure on blood basophil IL-13 secretion and FcεRIβ J Allergy Clin Immunol 114 2004 768 774
22. J.K. Burgess, S. Carlin, R.A. Pack, G.M. Arndt, W.W. Au, and P.R. Johnson Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? J Allergy Clin Immunol 113 2004 683 689
23. P.R. Johnson, J.K. Burgess, P.A. Underwood, W. Au, M.H. Poniris, and M. Tamm Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism J Allergy Clin Immunol 113 2004 690 696
24. S. Zuyderduyn, P.S. Hiemstra, and K.F. Rabe TGF-β differentially regulates TH2 cytokine-induced eotaxin and eotaxin-3 release by human airway smooth muscle cells J Allergy Clin Immunol 114 2004 791 798
25. S. Ying, B.J. O'Connor, Q. Meng, N. Woodman, S. Greenaway, and H. Wong Expression of prostaglandin E(2) receptor subtypes on cells in sputum from patients with asthma and controls: effect of allergen inhalational challenge J Allergy Clin Immunol 114 2004 1309 1316
26. J.K. Burgess, Q. Ge, S. Boustany, J.L. Black, and P.R. Johnson Increased sensitivity of asthmatic airway smooth muscle cells to prostaglandin E2 might be mediated by increased numbers of E-prostanoid receptors J Allergy Clin Immunol 113 2004 876 881
27. K. Parameswaran, H. Liang, A. Fanat, R. Watson, D.P. Snider, and P.M. O'Byrne Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma J Allergy Clin Immunol 114 2004 73 79
28. K.S. Lee, S.R. Kim, H.S. Park, G.Y. Jin, and Y.C. Lee Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression J Allergy Clin Immunol 114 2004 1093 1099
29. B. Mahut, C. Delclaux, I. Tillie-Leblond, P. Gosset, C. Delacourt, and F. Zerah-Lancner Both inflammation and remodeling influence nitric oxide output in children with refractory asthma J Allergy Clin Immunol 113 2004 252 256
30. S.P. Sanders, D. Proud, S. Permutt, E.S. Siekierski, R. Yachechko, and M.C. Liu Role of nasal nitric oxide in the resolution of experimental rhinovirus infection J Allergy Clin Immunol 113 2004 697 702
31. S. Isogai, S. Miyata, R. Taha, Y. Yoshizawa, J.G. Martin, and Q. Hamid CD4+ T cells migrate from airway to bone marrow after antigen inhalation in rats J Allergy Clin Immunol 113 2004 455 461
32. S. Isogai, R. Taha, M. Tamaoka, Y. Yoshizawa, Q. Hamid, and J.G. Martin CD8+ αβ T cells can mediate late airway responses and airway eosinophilia in rats J Allergy Clin Immunol 114 2004 1345 1352
33. B.A. Raby, E.K. Silverman, D.J. Kwiatkowski, C. Lange, R. Lazarus, and S.T. Weiss ADAM33 polymorphisms and phenotype associations in childhood asthma J Allergy Clin Immunol 113 2004 1071 1078
34. P. Van Eerdewegh, R.D. Little, J. Dupuis, R.G. Del Mastro, K. Falls, and J. Simon Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness Nature 418 2002 426 430
35. M.C. Munthe-Kaas, K.H. Carlsen, P.J. Helms, J. Gerritsen, M. Whyte, and M. Feijen CTLA-4 polymorphisms in allergy and asthma and the TH1/ TH2 paradigm J Allergy Clin Immunol 114 2004 280 287
36. W. Eder, W. Klimecki, L. Yu, E. Von Mutius, J. Riedler, and C. Braun-Fahrlander Toll-like receptor 2 as a major gene for asthma in children of European farmers J Allergy Clin Immunol 113 2004 482 488
37. B.M. Fageras, M. Hmani-Aifa, A. Lindstrom, M.C. Jenmalm, X.M. Mai, and L. Nilsson A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children J Allergy Clin Immunol 114 2004 561 567